John A. Meyers, PhD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Research Implementation Section

MA, Boston University
PhD, Boston University School of Medicine



Expertise includes: CLL; Leukemia; Lymphoid malignancies; B cell signaling; T cell development; Autoimmunity; cAMP signaling; Flow cytometry; Big Data anlaytics; and Informatics.

Boston Medical Center


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Xu C, Wyman AR, Alaamery MA, Argueta SA, Ivey FD, Meyers JA, Lerner A, Burdo TH, Connolly T, Hoffman CS, Chiles TC. Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes. Int Immunopharmacol. 2016 Sep; 38:223-32.View Related Profiles. PMID: 27302770; DOI: 10.1016/j.intimp.2016.06.004;.
  2. Tan Y, Watkins AA, Freeman BB, Meyers JA, Rifkin IR, Lerner A. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. J Immunol. 2015 Jan 1; 194(1):101-12.View Related Profiles. PMID: 25416804; PMCID: PMC4333002.
  3. Meyers JA, Su DW, Lerner A. Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors. J Immunol. 2009 May 1; 182(9):5400-11.View Related Profiles. PMID: 19380787; PMCID: PMC2676892; DOI: 10.4049/jimmunol.0804255;.
  4. Meyers JA, Taverna J, Chaves J, Makkinje A, Lerner A. Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells. Clin Cancer Res. 2007 Aug 15; 13(16):4920-7.View Related Profiles. PMID: 17699872; PMCID: PMC2656255.
  5. Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem. 2007 Jun 15; 282(24):17475-85.View Related Profiles. PMID: 17446175.
  6. Everett PC, Meyers JA, Makkinje A, Rabbi M, Lerner A. Preclinical assessment of curcumin as a potential therapy for B-CLL. Am J Hematol. 2007 Jan; 82(1):23-30.View Related Profiles. PMID: 16947318.
  7. Meyers JA, Mangini AJ, Nagai T, Roff CF, Sehy D, van Seventer GA, van Seventer JM. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine. 2006 Sep; 35(5-6):235-46.View Related Profiles. PMID: 17052915.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 7 publications over 5 distinct years, with a maximum of 3 publications in 2007

YearPublications
20061
20073
20091
20151
20161
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

immunology
phospho-flow
Contact for Mentoring:


650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map


Meyers's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department